David Iggman, MD, PhD; Johan Ärnlöv, MD, PhD; Tommy Cederholm, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(7):745-753. doi:10.1001/jamacardio.2016.2259
This cohort study investigated associations between adipose tissue fatty acids and cardiovascular and overall mortality in a cohort of elderly men.
Stacy Tessler Lindau, MD, MAPP; Emily Abramsohn, MPH; Hector Bueno, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(7):754-764. doi:10.1001/jamacardio.2016.2362
This cohort study describes the sexual activity and function of younger women and men ages 18-55 in the United States and Spain in the year after they experience an acute myocardial infarction.
Taulant Muka, MD, PhD; Clare Oliver-Williams, PhD; Setor Kunutsor, MD, PhD; et al.
free access
has audio
JAMA Cardiol. 2016;1(7):767-776. doi:10.1001/jamacardio.2016.2415
This meta-analysis systematically reviews and meta-analyzes studies evaluating the effect of age at onset of menopause and time since onset of menopause on intermediate cardiovascular disease end points, cardiovascular disease outcomes, and all-cause mortality.
-
Podcast:
Association of Age at and Time Since Menopause With Cardiovascular Outcomes (JAMA Cardiology)
Amit J. Shah, MD, MSCR; Viola Vaccarino, MD, PhD; A. Cecile J. W. Janssens, PhD; et al.
free access
JAMA Cardiol. 2016;1(7):779-786. doi:10.1001/jamacardio.2016.2173
This cohort study uses NHANES data to compare the ability of the Framingham risk score with vs without ECG measures to predict 10-year ischemic heart disease and all-cause mortality.
Jacob A. Doll, MD; Anne S. Hellkamp, MS; Abhinav Goyal, MD; et al.
free access
JAMA Cardiol. 2016;1(7):787-794. doi:10.1001/jamacardio.2016.2724
This study of a national myocardial infarction registry examines the association of dual Medicare-Medicaid eligibility status with clinical outcomes and medication adherence among older adults after myocardial infarction.
Anna Franzone, MD; Raffaele Piccolo, MD; Giuseppe Gargiulo, MD; et al.
free access
JAMA Cardiol. 2016;1(7):795-803. doi:10.1001/jamacardio.2016.2811
This subanalysis of PRODIGY trial data compares the efficacy and safety of prolonged vs short dual antiplatelet therapy after percutaneous coronary intervention in patients with vs without peripheral arterial disease.
David M. Dudzinski, MD, JD; R. Sacha Bhatia, MD, MBA; Michael Y. Mi, MD; et al.
free access
JAMA Cardiol. 2016;1(7):805-812. doi:10.1001/jamacardio.2016.2232
This randomized trial compares the effects of an educational intervention with vs without feedback on the ordering of 鈥渞arely appropriate鈥� transthoracic echocardiograms by academic attending cardiologists.
Fiona Bragg, MRCP; Liming Li, MD, MPH; Derrick Bennett, PhD; et al.
open access
JAMA Cardiol. 2016;1(7):813-823. doi:10.1001/jamacardio.2016.1702
This cohort study examines associations between random plasma glucose levels and risk for major cardiovascular disease among Chinese adults without known diabetes.
-
Invited Commentary
Random Plasma Glucose Levels and Cardiovascular Risk
Lijing L. Yan, PhD, MPH; Heng Jiang; Carolyn S. P. Lam, MBBS, PhD
JAMA Cardiol